Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial.
Najibah A GaladanciShehu U AbdullahiShehi Ali AbubakarBinta Wudil JibirHauwa AminuAliyu TijjaniMuhammad S AbbaMusa A TabariAisha GaladanciAwwal Musa BorodoRaymond BelonwuAuwal S SalihuMark RodeghierDjamila L GhafuriBrittany V Covert C GreeneKathleen NevilleAdetola A KassimFenella Jane KirkhamLori C JordanMuktar H AliyuMichael Rutledge DeBaunPublished in: American journal of hematology (2020)